National Health Investors Inc (STU:WX6)
€ 70.5 +0.50 (+0.71%) Market Cap: 3.43 Bil Enterprise Value: 4.54 Bil PE Ratio: 25.98 PB Ratio: 2.58 GF Score: 83/100

Q1 2025 National Health Investors Inc Earnings Call Transcript

May 06, 2025 / 02:00PM GMT
Release Date Price: €67.5 (+3.05%)

Key Points

Positve
  • National Health Investors Inc (NHI) exceeded expectations in the first quarter of 2025, driven by a faster pace of acquisitions and better-than-expected cash rent collections.
  • The company raised its normalized FFO guidance midpoint by $0.08 per share to $4.71, representing a year-over-year growth of 6.1%.
  • NHI announced investments of $174.9 million so far in 2025, with an active pipeline of approximately $264 million, indicating strong growth potential.
  • The balance sheet remains strong, with a net debt to adjusted EBITDA ratio of 4.1 times, supporting significant investment opportunities.
  • NHI's shop operations are expected to achieve 12% to 15% NOI growth this year, with positive trends in occupancy and resident fees.
Negative
  • NHI recorded a $1.2 million charge in transaction costs for a large shop portfolio deal that was ultimately not pursued, indicating potential inefficiencies in deal evaluation.
  • The shop segment experienced a decline in margin by 10 basis points to 22.1% compared to the prior year period, reflecting operational challenges.
  • There is uncertainty regarding the impact of potential Medicaid cuts on the portfolio, which could affect future revenue streams.
  • The company experienced a sequential decline in occupancy in the shop segment, attributed to typical seasonality and higher move-outs.
  • NHI's reliance on incentives to maintain occupancy levels in certain properties suggests ongoing challenges in stabilizing the portfolio.
Operator

Greetings. Welcome to National Health Investors first-quarter 2025 earnings webcast and conference call.(Operator instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, Dana Hambly, Vice President, Finance and Investor Relations. You may begin.

Dana Hambly
National Health Investors Inc - Director of Investor Relations

Thank you and welcome to the National Health Investors conference call to review results for the first quarter of 2025. On the call today are Eric Mendelsohn, President and CEO; Kevin Pascoe, Chief Investment Officer; John Spaid, Chief Financial Officer; and David Travis, Chief Accounting Officer.

The results, as well as notice of the accessibility of this conference call were released after the market closed yesterday in a press release that's been covered by the financial media. Any statements in this conference call, which are not historical facts are forward-looking statements. NHI cautions investors that any forward-looking statement may involve risks or uncertainties

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot